Design and rationale of a pragmatic randomized clinical trial of early dronedarone versus usual care to change and improve outcomes in persons with first-detected atrial fibrillation – the CHANGE AFIB study

Authors: Pokorney, Sean D., Nemeth, Hayley, Chiswell, Karen, Albert, Christine, Allyn, Nadine, Blanco, Rosalia, Butler, Javed, Calkins, Hugh, Elkind, Mitchell S.V., Fonarow, Gregg C., Fontaine, John M., Frankel, David S., Fermann, Gregory J., Gale, Rex, Kalscheur, Matthew, Kirchhof, Paulus, Koren, Andrew, Miller, Joseph B., Rashkin, Jason, Russo, Andrea M., Rutan, Christine, Steinberg, Benjamin A., Piccini, Jonathan P.

Source: In American Heart Journal January 2025 279:66-75

Impact of electrical cardioversion on quality of life for patients with symptomatic persistent atrial fibrillation: Is there a treatment expectation effect?

Authors: Ha, Andrew C.T., Stewart, John, Klein, George, Roy, Denis, Connolly, Stuart, Koren, Andrew, Dorian, Paul

Source: In American Heart Journal August 2020 226:152-160

Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry

Authors: Lowenstern, Angela, Li, Shuang, Virani, Salim S., Navar, Ann Marie, Li, Zhuokai, Robinson, Jennifer G., Roger, Veronique L., Goldberg, Anne C., Koren, Andrew, Louie, Michael J., Peterson, Eric D., Wang, Tracy Y.

Source: In American Heart Journal July 2020 225:88-96

Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors

Authors: Go, Alan S., Ambrosy, Andrew P., Kheder, Kevin, Fan, Dongjie, Sung, Sue Hee, Inveiss, Alda I., Romo-LeTourneau, Victoria, Thomas, Sheila M., Koren, Andrew, Lo, Joan C.

Source: In The American Journal of Cardiology 15 February 2020 125(4):534-541

Practice-level variation in statin use and low-density lipoprotein cholesterol control in the United States: Results from the Patient and Provider Assessment of Lipid Management (PALM) registry

Authors: Nanna, Michael G., Navar, Ann Marie, Wang, Tracy Y., Li, Shuang, Virani, Salim S., Li, Zhuokai, Robinson, Jennifer G., Roger, Veronique L., Wilson, Peter W.F., Goldberg, Anne C., Koren, Andrew, Louie, Michael J., Peterson, Eric D.

Source: In American Heart Journal August 2019 214:113-124

Alirocumab efficacy and safety by race and ethnicity: Analysis from 3 ODYSSEY phase 3 trials

Authors: Ferdinand, Keith C., Jacobson, Terry A., Koren, Andrew, Elassal, Joseph, Thompson, Desmond, Deedwania, Prakash

Source: In Journal of Clinical Lipidology July-August 2019 13(4):586-593

Efficacy and safety of dronedarone by atrial fibrillation history duration: Insights from the ATHENA study

Authors: Blomström‐Lundqvist, Carina, Marrouche, Nassir, Connolly, Stuart, Corp dit Genti, Valérie, Wieloch, Mattias, Koren, Andrew, Hohnloser, Stefan H.

Source: Clinical cardiology. 43(12):1469-1477

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100122588054.0x000001&indx=1&recIds=ETOCvdc_100122588054.0x000001

Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter: Insights from the ATHENA study

Authors: Vamos, Mate, Calkins, Hugh, Kowey, Peter R., Torp‐Pedersen, Christian T., Corp dit Genti, Valérie, Wieloch, Mattias, Koren, Andrew, Hohnloser, Stefan H.

Source: Clinical cardiology. 43(3):291-297

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103350272.0x000001&indx=1&recIds=ETOCvdc_100103350272.0x000001

Dronedarone treatment following cardioversion in patients with atrial fibrillation/flutter: A post hoc analysis of the EURIDIS and ADONIS trials

Authors: Thind, Munveer, Crijns, Harry J., Naccarelli, Gerald V., Reiffel, James A., Corp dit Genti, Valérie, Wieloch, Mattias, Koren, Andrew, Kowey, Peter R.

Source: Journal of cardiovascular electrophysiology. 31(5):1022-1030

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107710941.0x000001&indx=1&recIds=ETOCvdc_100107710941.0x000001

Efficacy and safety of lipid lowering by alirocumab in chronic kidney disease

Authors: Toth, Peter P., Dwyer, Jamie P., Cannon, Christopher P., Colhoun, Helen M., Rader, Daniel J., Upadhyay, Ashish, Louie, Michael J., Koren, Andrew, Letierce, Alexia, Mandel, Jonas, Banach, Maciej

Source: In Kidney International June 2018 93(6):1397-1408

Alirocumab in high-risk patients: Observations from the open-label expanded use program

Authors: Glueck, Charles J., Brown, Alan, Goldberg, Anne C., McKenney, James M., Kantaros, Louis, Stewart, John, Elassal, Joseph, Koren, Andrew

Source: In Journal of Clinical Lipidology May-June 2018 12(3):662-668

Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)

Authors: McCullough, Peter A. ^*, Ballantyne, Christie M., Sanganalmath, Santosh K., Langslet, Gisle, Baum, Seth J., Shah, Prediman K., Koren, Andrew, Mandel, Jonas, Davidson, Michael H.

Source: In The American Journal of Cardiology 15 April 2018 121(8):940-948

Impact of Age on the Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia

Authors: Ginsberg, Henry N., Tuomilehto, Jaakko, Hovingh, G. Kees, Cariou, Bertrand, Santos, Raul D., Brown, Alan S., Sanganalmath, Santosh K., Koren, Andrew, Thompson, Desmond, Raal, Frederick J.

Source: Cardiovascular drugs and therapy. 33(1):69-76

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100127260070.0x000001&indx=1&recIds=ETOCvdc_100127260070.0x000001

Efficacy and safety of alirocumab among individuals with diabetes mellitus and atherosclerotic cardiovascular disease in the ODYSSEY phase 3 trials

Authors: Ganda, Om P., Plutzky, Jorge, Sanganalmath, Santosh K., Bujas‐Bobanovic, Maja, Koren, Andrew, Mandel, Jonas, Letierce, Alexia, Leiter, Lawrence A.

Source: Diabetes, obesity & metabolism. 20(10):2389-2398

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100096024908.0x000001&indx=1&recIds=ETOCvdc_100096024908.0x000001

Development and Validation of Algorithms to Identify Statin Intolerance in a US Administrative Database

Authors: Schulman, Kathy L., Lamerato, Lois E., Dalal, Mehul R., Sung, Jennifer, Jhaveri, Mehul, Koren, Andrew, Mallya, Usha G., Foody, JoAnne M.

Source: In Value in Health September-October 2016 19(6):852-860

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease

Authors: Mallya, Usha G., Boklage, Susan H., Koren, Andrew, Delea, Thomas E., Mullins, C. Daniel

Source: PharmacoEconomics. 36(1):115-126

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100130221071.0x000001&indx=1&recIds=ETOCvdc_100130221071.0x000001

Assessment of Dronedarone Utilization Using US Claims Databases

Authors: Wu, Jasmanda, Thammakhoune, Jane, Dai, Wanju, Koren, Andrew, Tcherny-Lessenot, Stephanie, Wu, Chuntao, Caubel, Patrick, Juhaeri, Juhaeri

Source: In Clinical Therapeutics 1 February 2014 36(2):264-272

Patterns of Statin Use in a Real-World Population of Patients at High Cardiovascular Risk

Authors: Lin, Iris, Sung, Jennifer, Sanchez, Robert J., Mallya, Usha G., Friedman, Mark, Panaccio, Mary, Koren, Andrew, Neumann, Peter, Menzin, Joseph

Source: Journal of managed care & speciality pharmacy. 22(6):685-698

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN606528423&indx=1&recIds=ETOCRN606528423

Placing in-vitro heteroresistance in the context of clinical results

Authors: Bassetti, Matteo, Echols, Roger, Koren, Andrew, Karas, Andreas, Longshaw, Chris, Yamano, Yoshinori, Den Nagata, Tsutae

Source: Lancet infectious diseases. 21(7):908-909

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100139446180.0x000001&indx=1&recIds=ETOCvdc_100139446180.0x000001

Evaluation of Dronedarone Use in the US Patient Population Between 2009 and 2010: A Descriptive Study Using a Claims Database

Authors: Gao, Shujun, Juhaeri, Juhaeri, Schiappacasse, Heather A., Koren, Andrew T., Dai, Wanju S.

Source: In Clinical Therapeutics 2011 33(10):1483-1490